Free tool
Drug Trial Radar: Ophthalmology
Last checked: Nov 20, 2026Latest source record: Jul 15, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
5
Recruiting, industry sponsors, Ophthalmology, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed188
5 trials
Showing 1 to 5, recently updated first.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
NCT07663331 · 30 participants (planned) · Start Jul 14, 2026 · Primary completion Feb 2028
Drug: TyboWe® Adalimumab Injection · For: Adult Non-infectious Uveitis
Sites: Tianjin, China
Andover Research Eye InstituteIndustry
NCT07676084 · 60 participants (planned) · Start Jun 3, 2026 · Primary completion Oct 2026
Drug: Preservative Free Polyethylene glycol 400 0.25%; Propylene Glycol (0.6%) and 1 more · For: Dry Eye Disease (DED)
Sites: Andover, Massachusetts
- Travoprost Intraocular Implant + iStent InfinitePivotal-lookingRecruiting
Glaukos CorporationIndustry
NCT06066645 · 150 participants (planned) · Start Sep 14, 2023 · Primary completion May 2027
Drug: Travoprost Intraocular Implant · For: Glaucoma, Open-Angle
Sites: Oklahoma City, Oklahoma
Ace Cells Lab LimitedIndustry
NCT07191847 · 300 participants (planned) · Start Apr 22, 2025 · Primary completion Dec 1, 2025
Drug: eye drops · For: Dry Eye; Cataract
Sites: Giza, Egypt
Alimera SciencesIndustry
NCT06539481 · 25 participants (planned) · Start Aug 31, 2024 · Primary completion Jul 15, 2026
Drug: fluocinolone acetonide 190 micrograms · For: Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Sites: Berlin, Germany; Münster, Germany; Bilbao, Spain · 6 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.